🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-15
Trial ID
NCT00619424
Treatments Being Tested
The purpose of this study is to evaluate sacituzumab tirumotecan versus pem...
Status
Active Not Recruiting
Location
Kaiser Permanente - Oakland ( Site 0054)
Start Date
2024-06-11
Trial ID
NCT06305754
The purpose of this study is to determine the effectiveness and safety of A...
Status
Unknown
Location
Multiple Locations
Start Date
2018-01-04
Trial ID
NCT03390062
Treatments Being Tested
In this study with a modified 3+3 dose finding design, a safe and tolerable...
Status
Unknown
Location
Department of Neurology and Center of Integrated Oncology, University Hospital Bonn
Start Date
2013-10
Trial ID
NCT01972750
Treatments Being Tested
The investigators propose to test the hypothesis that the sympathetic nervo...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2007-04
Trial ID
NCT00580619
Treatments Being Tested
This is a study of Camrelizumab combined with Apatinib versus Apatinib alon...
Status
Unknown
Location
The Sixth Affiliated hosipital, Sun Yat-Sen University
Start Date
2022-05-01
Trial ID
NCT05342389
Treatments Being Tested
This is an open-label, continuous daily dosing, two-part safety and efficac...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2006-01-18
Trial ID
NCT00261846
Treatments Being Tested
This is a randomized, open-label, multicenter Phase 3 clinical study to eva...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2023-06-26
Trial ID
NCT05870319
Treatments Being Tested
This Phase I clinical trial evaluates the safety, tolerability, and optimal...
Status
Recruiting
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2025-09-29
Trial ID
NCT06912087
Treatments Being Tested
The purpose of the study is to determine the optimal safe and tolerable dos...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2004-10
Trial ID
NCT00185588
Treatments Being Tested